RBC Capital Maintains Outperform on Johnson & Johnson, Lowers Price Target to $280

Benzinga · 1d ago
RBC Capital analyst Trung Huynh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $290 to $280.